Mandelia Ashish

VP, Chief Accounting Officer at Mersana Therapeutics, Inc.

Sold, on record
$173k
Dollars the filings state
Form 4 sales
11
Latest Jan 16, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Mersana Therapeutics, Inc.Unusual
    Jul 1, 2021 2021

    Sold 942 shares at $13.60 ($13k)

    Mandelia Ashish, VP, Controller

    Sold 100% of holdings ($13k position)0 shares left1.7x usual sizeFiling

  2. 2 Form 4 sale Mersana Therapeutics, Inc.Unusual
    Jan 18, 2022 +201 days

    Sold 1,982 shares at $5.92 ($12k)

    Mandelia Ashish, VP, Controller

    Sold 37% of holdings ($32k position)3,371 shares left2.7x usual sizeFiling

  3. 3 Form 4 sale Mersana Therapeutics, Inc.Unusual
    Jan 17, 2023 +364 days

    Sold 3,575 shares at $5.74 ($21k)

    Mandelia Ashish, VP, Controller

    Sold 20.8% of holdings ($99k position)13,619 shares left3.8x usual sizeFiling

  4. 4 Form 4 sale Mersana Therapeutics, Inc.Routine
    Jan 16, 2024 +364 days

    Sold 5,025 shares at $2.71 ($14k)

    Mandelia Ashish, VP, Chief Accounting Officer

    10b5-1 planSold 17.7% of holdings ($77k position)23,328 shares leftFiling

  5. 5 Form 4 sale Mersana Therapeutics, Inc.Routine
    Oct 3, 2024 +261 days

    Sold 8,216 shares at $1.98 ($16k)

    Mandelia Ashish, VP, Chief Accounting Officer

    10b5-1 planSold 14.7% of holdings ($111k position)47,757 shares leftFiling

  6. 6 Form 4 sale Mersana Therapeutics, Inc.Routine
    Jan 14, 2025 +103 days

    Sold 1,007 shares at $0.66 ($665)

    Mandelia Ashish, VP, Chief Accounting Officer

    10b5-1 planSold 2% of holdings ($33k position)49,396 shares left0.2x usual sizeFiling

  7. 7 Form 4 sale Mersana Therapeutics, Inc.Routine
    Jan 15, 2025 +1 day

    Sold 1,791 shares at $0.63 ($1k)

    Mandelia Ashish, VP, Chief Accounting Officer

    10b5-1 planSold 3.3% of holdings ($34k position)52,388 shares left0.4x usual sizeFiling

  8. 8 Form 4 sale Mersana Therapeutics, Inc.Routine
    Jan 16, 2025 +1 day

    Sold 3,554 shares at $0.58 ($2k)

    Mandelia Ashish, VP, Chief Accounting Officer

    10b5-1 planSold 5.8% of holdings ($35k position)57,519 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Mandelia Ashish
Source
Jan 16, 2025Jan 17, 2025Mersana Therapeutics, Inc.VP, Chief Accounting OfficerForm 4 sale3,554$2k5.8%RoutineSEC
Jan 15, 2025Jan 16, 2025Mersana Therapeutics, Inc.VP, Chief Accounting OfficerForm 4 sale1,791$1k3.3%RoutineSEC
Jan 14, 2025Jan 15, 2025Mersana Therapeutics, Inc.VP, Chief Accounting OfficerForm 4 sale1,007$6652.0%RoutineSEC
Oct 3, 2024Oct 7, 2024Mersana Therapeutics, Inc.VP, Chief Accounting OfficerForm 4 sale8,216$16k14.7%RoutineSEC
Jan 16, 2024Jan 17, 2024Mersana Therapeutics, Inc.VP, Chief Accounting OfficerForm 4 sale5,025$14k17.7%RoutineSEC
Jan 17, 2023Jan 18, 2023Mersana Therapeutics, Inc.VP, ControllerForm 4 sale3,575$21k20.8%UnusualSEC
Jan 18, 2022Jan 19, 2022Mersana Therapeutics, Inc.VP, ControllerForm 4 sale1,982$12k37.0%UnusualSEC
Jul 1, 2021Jul 2, 2021Mersana Therapeutics, Inc.VP, ControllerForm 4 sale942$13k100.0%UnusualSEC
Jan 19, 2021Jan 20, 2021Mersana Therapeutics, Inc.VP, ControllerForm 4 sale545$12k100.0%UnusualSEC
Jan 4, 2021Jan 6, 2021Mersana Therapeutics, Inc.VP, ControllerForm 4 sale247$7k100.0%UnusualSEC
Jul 2, 2020Jul 6, 2020Mersana Therapeutics, Inc.VP, ControllerForm 4 sale3,383$76k100.0%UnusualSEC